Treatment of Primary Hyperoxaluria Type 1 With Nedosiran
Clinical trial NCT05993416 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT05993416
- Sponsor
- Dicerna Pharmaceuticals, Inc., a Novo Nordisk company
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.